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Of LAP, CUPS, and DRibbles – 
unconventional use of autophagy 
proteins for MHC restricted antigen 
presentation
Christian Münz*
 Viral Immunobiology, Institute of Experimental Immunology, University of Zürich, Zurich, Switzerland
Macroautophagy delivers cytoplasmic constituents for lysosomal degradation. Because 
MHC class II molecules are loaded with lysosomal products for CD4+ T-cell stimulation, 
macroautophagy supports intracellular antigen processing onto MHC class II molecules. 
The molecular machinery of macroautophagy, however, does not only support this auto-
phagic antigen processing, but seems to also modify extracellular antigen uptake for MHC 
class II presentation, antigen exocytosis, and packaging for improved cross-presentation 
onto MHC class I molecules. The different membrane trafficking pathways with LC3-
associated phagocytosis, compartment for unconventional protein secretion, and DRibbles 
as well as the role that autophagic proteins play in them will be discussed in this review.
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introduction
Autophagy describes several pathways, by which cytoplasmic constituents gain access to lysosomal 
degradation (1). During one of these autophagic pathways, called macroautophagy, a dedicated vesicle, 
the autophagosome, is formed, which engulfs with two membranes its cytoplasmic cargo and then 
fuses with lysosomes for degradation of its inner autophagosomal membrane and its contents.
The Molecular Machinery of Macroautophagy
The extensive membrane remodeling events that first generate the cup-shaped isolation membrane, 
which then closes to autophagosomes and gets directed to fusion with late endosomes or lysosomes, 
require >30 essential proteins, which were termed autophagy-related gene (Atg) products. They are 
grouped in distinct complexes (ULK1 complex, Atg9L, the class III PI3K complex, the WIPI–Atg2 
complex, the Atg12 conjugation complex, and the Atg8 conjugation complex). The Atg1/ULK1 
complex (ULK1/2, Atg13, Atg101, and FIP200) is under metabolic control and can be activated by 
AMP activated protein kinase (AMPK) and inhibited by target of rapamycin (TOR), both through 
phosphorylation. The ULK1 complex induces macroautophagy during nutrient depletion to recycle 
cellular constituents for survival. This constitutes the canonical function of macroautophagy. The 
ULK1 complex in turn phosphorylates members of the class III PI3K complex (Vps34, Atg14L, 
Beclin-1, and Vps15), including Atg6/Beclin-1, which activates phosphatidylinositol 3-phosphate 
(PI3P) deposition at membrane sites like the ER, where autophagosomes are generated. Atg9L most 
likely recruits membranes to these sites after phosphorylation by the ULK1 complex. The PI3P marks 
recruit WIPI–Atg2 complexes to these membrane sites, which function as landing platforms for the 
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Atg12–Atg5/Atg16L1 complexes via direct binding of Atg16L1 
to WIPI2. These interactions lead to autophagosome initiation.
For autophagosome elongation, the Atg12–Atg5/Atg16L1 com-
plexes assemble after ubiquitin-like coupling of Atg12–Atg5 via the 
E1- and E2-like enzymes, Atg7 and Atg10, and binding of Atg16L1 
to the resulting conjugate. The Atg12–Atg5/Atg16L1 complex 
fulfills the E3-like enzymatic activity for the other ubiquitin-like 
system that couples Atg8 to phosphatidylethanolamine (PE) in 
the assembling autophagosome membrane called the phagophore 
or isolation membrane. Prior to conjugation five amino acids are 
removed from the C-terminus of Atg8 by the protease Atg4, and 
Atg8 is then activated and conjugated by Atg7 and Atg3. Atg8 has 
eight mammalian orthologs (two splice variants of LC3A, LC3B, 
LC3C, GABARAP, and GABARAPL1-3). The PE coupled forms 
of these Atg8 orthologs can be distinguished from their cytosolic 
form by SDS gel electrophoresis. LC3B-PE is assessed most often 
for this purpose and migrates faster (LC3B-II) than its cytosolic 
form (LC3B-I). These autophagic protein tags are conjugated to 
the outer and inner membrane of the developing autophagosome 
and seem to mediate membrane fusion events during phagophore 
elongation and recruit substrates into autophagosomes via LC3 
interacting regions (LIRs). Once the autophagosome is completed 
the Atg12–Atg5/Atg16L1 complex dissociates and Atg4 also cleaves 
Atg8 from the outer membrane. These molecular events lead to 
autophagosome completion.
For autophagosome maturation, however, residual Atg8 at 
the outer autophagosome membrane might facilitate migration 
along microtubules and fusion with lysosomes via recruitment 
of FYVE and coiled coil domain containing 1 (FYCO1) (2) and 
pleckstrin homology domain containing protein family member 
1 (PLEKHM1) proteins (3). Alternatively, FYCO1 and PLEKHM1 
could also be recruited by the lipid composition of the outer 
autophagosomal membrane, including PI3P. PLEKHM1 in turn 
seems to recruit the homotypic fusion and vacuole protein sort-
ing (HOPS) complex, the GTPase Rab7 that is involved in late 
endosome and autophagosome fusion with lysosomes, and even 
the SNARE syntaxin 17 (STX17), which executes outer autophago-
some membrane fusion with lysosomes. Autophagosome fusion 
with lysosomes is again regulated by type III PI3K complexes 
containing Vps34, Beclin-1, and VPS15. PI3K complexes con-
taining Rubicon inhibit, whereas UVRAG containing complexes 
accelerate autophagosome fusion with lysosomes. These findings 
indicate that some components of the fusion machinery are also 
recruited by PI3P to the autophagosomal membrane. Thus, mac-
roautophagy utilizes a sophisticated membrane remodeling and 
fusion machinery, which recently has been found to support other 
membrane trafficking events. This involvement of Atg proteins in 
endocytosis and exocytosis for antigen processing toward MHC 
restricted antigen presentation will be discussed in this review.
LC3-Associated Phagocytosis
MHC class I and II molecules present peptide products of pro-
teasomal and lysosomal proteolysis to CD8+ cytotoxic and CD4+ 
helper T-cells, respectively (4). Classically, endocytosed material 
is delivered to lysosomes and its fragments are then presented 
on MHC class II molecules. One prominent endocytic pathway 
is phagocytosis and Atg proteins have been found to regulate 
it during LC3-associated phagocytosis (LAP) (5) (Figure  1). 
During LAP, its cargo needs to engage a subset of phagocytic and/
or pathogen-associated molecular pattern (PAMP) receptors to 
recruit NADPH oxidase 2 (NOX2) to the phagosomal membrane 
(6, 7). These receptors can be members of the toll-like receptor 
(TLR) family, primarily TLR2, or the C-type lectin Dectin-1, the 
T-cell immunoglobulin mucin protein 4 (TIM4) or Fc receptors 
for immunoglobulins (5, 7–10). NOX2 either allows coupling 
of LC3 to phagosomes or prevents its uncoupling by Atg4, and 
this LC3 lipidation is independent of the Atg1/ULK1 complex 
(8). Irrespective of the exact mechanism, LC3 is coupled to the 
cytosolic side of the limiting phagosomal membrane (7) and 
influences the fate of these LAP phagosomes. In some cell types, 
primarily mouse macrophages, LAP phagosomes seem to fuse 
more rapidly than LC3 negative phagosomes with lysosomes (5, 
10, 11), whereas in human macrophages, conventional and plas-
macytoid dendritic cells (DCs), LAP vesicles seem to be stabilized 
and can fuse with TLR containing endosomes (7, 12). Acceleration 
of LAP phagosome fusion with lysosomes might be because of 
more efficient transport along microtubules via LC3 binding to 
FYVE and coiled-coil domain containing 1 (FYCO1) protein (11). 
Stabilized LAP phagosomes do not recruit Rab7 and do not seem 
to contain classical autophagy cargo like the LIR-positive sequesto-
some 1/p62 protein (7). Prior to delayed fusion of LAP vesicles with 
lysosomes, LC3 is uncoupled from the phagosomal membrane 
(7). This delayed phagosomal processing might be beneficial for 
continuous MHC class II antigen presentation of phagocytosed 
antigens. Indeed, LAP formation was required for prolonged 
antigen processing of Candida antigens for MHC class II presenta-
tion to specific human CD4+ T-cell clones in vitro (7). Similarly, 
Dectin-1 bound antigens were also more efficiently presented to 
mouse CD4+ T-cells (9). Finally, CD4+ T-cell priming after antigen 
injection into mice with Atg5-deficient DCs was compromised as 
compared to wild-type mice, suggesting that LAP improves MHC 
class II presentation of exogenous antigen in vivo, in addition to 
the role of Atg5 in endogenous antigen processing for MHC class 
II presentation (13). Indeed, retention of phagocytosed antigens by 
LAP might account in part for more efficient antigen presentation 
after attenuated lysosomal degradation (14). Therefore, regulation 
of phagocytosis by autophagic proteins seems to enhance MHC 
class II antigen presentation of extracellular antigens.
Compartment for Unconventional Protein 
Secretion
Autophagy-related gene proteins are also involved in unconventional 
membrane trafficking in the opposite direction of phagocytosis, 
namely signal peptide independent secretion (15). A number of 
proteins leave eukaryotes not via the classical ER to Golgi pathway 
and lack signal peptides for co-translational insertion into the ER. 
These include acyl-CoA binding protein 1 (Acb1), interleukin-1β, 
interleukin-33, tissue transglutaminase, galectin-3, macrophage 
migration inhibitory factor, and insulin-degrading enzyme (15). 
Recently, it was found that Acb1 and IL-1β require autophagic 
proteins for their secretion, namely Atg1, 5, 6, 7, 8, 9, 11, 12, and 
17 (16–18). Moreover, release of microbial peptides and secretory 
FiGURe 1 | Unconventional pathways that use autophagic proteins.  
(A) LC3-associated phagocytosis (LAP) is engaged on TLR2 ligand 
phagocytosis, which recruits NADPH oxidase (NOX2). NOX2 produce reactive 
oxygen species (ROS), which are required to recruit or maintain Atg8/LC3 at 
the phagosomal membrane. Atg8/LC3 needs to be cleaved from the 
phagosomal membrane for phagosomes to fuse with MHC class II loading 
compartments, and their cargo is degraded by lysosomal hydrolysis and 
fragments loaded onto MHC class II molecules for stimulation of CD4+ T-cells. 
(B) During unconventional secretion of proteins without signal peptides for 
co-translational insertion into the ER, Atg8/LC3 and Atg9L cooperate to 
expand the compartment for unconventional protein secretion (CUPS). Proteins 
to be secreted, like acyl-CoA binding protein 1 (Acb1), bind on the  
cytosolic side to these membranes, then vesicles from the CUPS fuse with 
multivesicular bodies (MVBs). Acb1 is internalized into intravesicular 
membranes by invagination and then released in exosomes after  
MVB fusion with the cell membrane. (C) Proteasomal inhibition diverts 
ubiquitinated proteins, including defective ribosomal products, into 
autophagosomes via sequestosome 1/p62 binding to polyubiquitin  
and Atg8/LC3. The inner autophagosomal membrane with this  
cargo is released as defective ribosomal products-containing  
autophagosome-rich blebs (DRibbles) if lysosomal degradation is  
inhibited.
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lysosomes was also found to be dependent on this autophagic core 
machinery (19–21). Interestingly, the secretion of Acb1 during 
yeast and ameba starvation requires the formation of a membrane 
structure close to the ER exit site that seems to be composed of 
cis- and trans-Golgi membranes and is called the compartment 
for unconventional protein secretion (CUPS) (22, 23) (Figure 1). 
It contains PI3P, Atg9, Atg8, the Golgi-associated protein GRASP65 
and Vps23 of the ESCRT-1 complex for multivesicular body (MVB) 
formation. Moreover, after starvation the CUPS is absorbed into the 
ER (23). Therefore, the CUPS might be a continuous membrane, 
which is elongated like the isolation membrane with the help of Atg 
proteins, but might never form a double-membrane surrounded 
autophagosome. Instead, the cargo for unconventional secretion 
seems to get attached to the cytosolic side of the membrane (15). 
Small Acb1-coated vesicles might then get released from CUPS and 
fuse with an endosomal compartment, on the surface of which they 
require the ESCRT-1 complex for invagination of the endosomal 
membrane to generate MVBs. These MVBs fuse then with the cell 
membrane to release exosomes that contain the unconventionally 
secreted substrate. Indeed, the surface membrane SNARE Sso1 has 
been found to be required for unconventional Acb1 secretion (17). 
Moreover, part of the IL-1β released from activated macrophages 
is membrane engulfed and therefore protease resistant (24). This 
unconventional secretion pathway could also give rise to immu-
nostimulatory exosomes, which have been proposed for efficient 
antigen delivery vesicles that already contain antigenic peptide 
loaded MHC molecules (25).
Defective Ribosomal Products-Containing 
Autophagosome-Rich Blebs
Such exosomal fractions might be further modified by autophago-
somes, which are not degraded in lysosomes. Indeed, loss of Atg5, 
Atg6/Beclin-1, or Atg12 compromised tumor and influenza A virus-
infected cells to donate antigens for efficient cross-presentation (26, 
27). Ubiquitinated proteins and defective ribosomal products, includ-
ing viral and tumor antigens, were enriched in vesicular fractions 
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of cell supernatants after blocking proteasomal and lysosomal 
degradation (28) (Figure 1). In the presence of proteasomal inhibi-
tion, ubiquitinated substrates of the proteasome seem to aggregate 
and get incorporated into autophagosomes via sequestosome1/p62, 
a protein that anchors ubiquitinated proteins to LC3 for autophagic 
substrate recruitment (29). Blocking lysosomal degradation might 
then generate autophagolysosomes with MVB characteristics, from 
which the inner autophagosomal membranes and their cargo might 
be released into the vesicular supernatant fraction. Similar pathways 
of arrested macroautophagy might be used by viruses to exit cells 
(30–33). These vesicular fractions were coined defective ribosomal 
products-containing autophagosome-rich blebs (DRibbles) and 
can be endocytosed in a CLEC9A-dependent fashion by antigen 
presenting cells (28). DRibbles seem to be more efficient for cross-
presentation on MHC class I molecules to CD8+ T-cells than cell 
lysates and soluble antigens (34). DRibbles were similarly processed 
for MHC class II presentation to CD4+ T-cells like whole cell lysates, 
but better than soluble viral antigens. The more efficient MHC class 
I cross-presentation could be further enhanced in human peripheral 
blood mononuclear cells by GM-CSF and TLR3 agonist addition 
(34). Furthermore, DRibbles immunization of mice protected from 
challenge with melanoma, lung carcinoma, breast carcinoma, and 
sarcoma cell lines (29, 35). Thus, frustrated macroautophagy of 
proteasomal substrates might lead to secretion of DRibbles, which 
could be a superior antigen format for cross-presentation on MHC 
class I molecules.
Conclusion
LAP, CUPS, and DRibbles bear witness to non-canonical func-
tions of Atg proteins. They have in common with macroautophagy 
that they regulate membrane trafficking and cargo delivery to 
topologically extracellular compartments (endosomes or cell 
supernatants during endocytosis and exocytosis, respectively). 
Atg proteins might facilitate membrane fusion events and 
recruit substrates and adaptor proteins during the trafficking 
of LAP- and CUPS-derived vesicles as well as during DRibbles 
secretion. A better understanding of these non-canonical Atg 
pathways should provide insights into how groups of Atg pro-
teins can be used by different cellular pathways in a modular 
fashion to achieve vesicle elongation, fusion with other vesicles 
and substrate recruitment. This knowledge would then also 
provide a better understanding of macroautophagy itself, the 
pathway that defined Atgs. Because MHC-restricted antigen 
presentation relies on cellular trafficking events to produce 
antigenic fragments, load them into MHC peptide binding 
grooves, and then transport the products to the cell surface 
for T-cell recognition, interference with the various Atg-
assisted pathways undoubtedly modulates T-cell recognition 
of antigens and these pathways should be harnessed during 
vaccination.
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